Prothena Corp PLC (STU:0PT)
€ 16.4 0.1 (0.61%) Market Cap: 881.85 Mil Enterprise Value: 370.47 Mil PE Ratio: 0 PB Ratio: 1.62 GF Score: 76/100

Prothena Corporation PLC at Bank of America Healthcare Conference Transcript

May 10, 2022 / 04:20PM GMT
Release Date Price: €25.98 (-5.80%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

And welcome to the Bank of America Healthcare Conference. We are continuing our sessions with our next presenting company, Prothena. It's my pleasure to have sitting next to me Gene Kinney as well as [Suzanne Lentzsch.] I'll let you guys introduce yourselves and for your titles and then maybe Gene after that, you can give us a 2-minute overview of the company, and we can go into Q&A on some topics.

Gene G. Kinney
Prothena Corporation plc - President, CEO & Director

Sounds great. Thank you. And [Suzanne,] you want to start?

Unidentified Company Representative

Yes, sure. Thank you, Tazeen for having us. [Suzanne Lentzsch,] Senior Vice President of Strategy and Operations.

Gene G. Kinney
Prothena Corporation plc - President, CEO & Director

Hi, everyone, I'm Gene Kinney, CEO of Prothena. And thank you very much for having us today. It's always great to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot